EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Refining Sentinel Lymph Node Biopsy Decisions for Clinically Node‐Negative Microinvasive DCIS

Cien Huang iD, Priyanka Parmar, Noor Habboosh, Fardeen Bhimani, Yu Chen, David Entenberg, Maja Oktay, Anjuli Gupta, Jessica Pastoriza, Maureen McEvoy, Sheldon Feldman iD

The Breast Journal · 2026-01 · 2026 (1)

DOI: 10.1155/tbj/5479226 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Breast Journal, online erschienen am 18.05.2026. Verfasst von Cien Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Albert Einstein College of Medicine, Bronx, New York, New York, USA, yu.edu. Hauptthemen laut MEDLINE: Sentinel Lymph Node Biopsy, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ductal carcinoma in situ with microinvasion (DCISM), defined as invasion ≤ 1 mm, occurs in 5%–10% of DCIS cases. There is ongoing debate on whether DCISM should be managed as DCIS or as small invasive cancer. As treatments increasingly emphasize minimizing morbidity, efforts have focused on identifying low‐risk patients who may safely forgo axillary surgery, including sentinel lymph node biopsy (SLNB). However, axillary management of DCISM remains unclear due to limited data. This study aims to identify preoperative predictors of upstaging to invasive carcinoma on final pathology to guide SLNB use.

Methods

A retrospective chart review was conducted of women aged ≥ 19 years with confirmed or suspected DCISM on initial biopsy who were clinically node negative and treated at a tertiary center from 2013 to 2023. Fisher’s exact test and Student′s t ‐test were used for categorical and continuous variables, respectively. Univariate and multivariate analyses were performed to identify predictors of upstaging.

Results

A total of 61 women with DCISM on initial biopsy were identified. Of these, 40.9% (25/61) were upstaged to invasive carcinoma on final pathology. Among upstaged patients, 95% (19/20) underwent SLNB at the time of surgery, and 12.5% (3/24) had positive lymph nodes. Time from biopsy to surgery did not differ significantly between groups ( p = 0.12). Preoperative predictors of upstaging included palpable mass (OR 9.0, 95% CI 2.38–44.98, p = 0.003), mass on mammogram (OR 12.86, 95% CI 1.95–255.34, p = 0.02), and mass with calcifications (OR 13.34, 95% CI 1.30–255.08, p = 0.047).

Conclusion

Clinically node‐negative DCISM patients without a palpable or mammographic mass (with or without calcifications) had a low risk of upstaging and lymph node involvement, suggesting that they may safely forgo SLNB. Identifying preoperative variables can guide risk stratifications and de‐escalation of axillary surgery. Larger prospective studies are needed to further inform guidelines for DCISM management in diverse populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sentinel Lymph Node BiopsyBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingHumansFemaleRetrospective StudiesMiddle AgedAdultAgedNeoplasm StagingLymphatic Metastasis

Autor:innen und Institutionen

  • Albert Einstein College of Medicine, Bronx, New York, New York, USA, yu.edu.
  • Department of Surgery, Montefiore Medical Center, Bronx, New York, New York, USA, montefiore.org.
  • Department of Breast Surgery, Montefiore Einstein Comprehensive Cancer Center, Bronx, New York, New York, USA.
  • Department of Pathology, Albert Einstein College of Medicine, Bronx, New York, New York, USA, yu.edu.

ORCID-Profile: Cien Huang, Sheldon Feldman

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Huang, C., Parmar, P., Habboosh, N., Bhimani, F., Chen, Y., Entenberg, D., Oktay, M., Gupta, A., Pastoriza, J., McEvoy, M., & Feldman, S. (2026). Refining Sentinel Lymph Node Biopsy Decisions for Clinically Node‐Negative Microinvasive DCIS. The Breast Journal, 2026(1). https://doi.org/10.1155/tbj/5479226

Vancouver

Huang C, Parmar P, Habboosh N, Bhimani F, Chen Y, Entenberg D, et al. Refining Sentinel Lymph Node Biopsy Decisions for Clinically Node‐Negative Microinvasive DCIS. The Breast Journal. 2026;2026(1). doi:10.1155/tbj/5479226

BibTeX
@article{Huang2026,
  author = {Huang, Cien and Parmar, Priyanka and Habboosh, Noor and Bhimani, Fardeen and Chen, Yu and Entenberg, David and Oktay, Maja and Gupta, Anjuli and Pastoriza, Jessica and McEvoy, Maureen and Feldman, Sheldon},
  title = {Refining Sentinel Lymph Node Biopsy Decisions for Clinically Node‐Negative Microinvasive DCIS},
  journal = {The Breast Journal},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/tbj/5479226}
}
Kostenlos starten →